IRIS Accounts Production v25.2.0.378 07254368 director 1.1.24 31.12.24 31.12.24 26.9.25 0 0 false true false false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072543682023-12-31072543682024-12-31072543682024-01-012024-12-31072543682022-12-31072543682023-01-012023-12-31072543682023-12-3107254368ns15:EnglandWales2024-01-012024-12-3107254368ns14:PoundSterling2024-01-012024-12-3107254368ns10:Director12024-01-012024-12-3107254368ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3107254368ns10:SmallEntities2024-01-012024-12-3107254368ns10:Audited2024-01-012024-12-3107254368ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3107254368ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3107254368ns10:FullAccounts2024-01-012024-12-310725436812024-01-012024-12-3107254368ns10:CompanySecretary12024-01-012024-12-3107254368ns10:RegisteredOffice2024-01-012024-12-3107254368ns5:CurrentFinancialInstruments2024-12-3107254368ns5:CurrentFinancialInstruments2023-12-3107254368ns5:ShareCapital2024-12-3107254368ns5:ShareCapital2023-12-3107254368ns5:RetainedEarningsAccumulatedLosses2024-12-3107254368ns5:RetainedEarningsAccumulatedLosses2023-12-3107254368ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107254368ns5:IntangibleAssetsOtherThanGoodwill2023-12-3107254368ns5:IntangibleAssetsOtherThanGoodwill2024-12-3107254368ns5:IntangibleAssetsOtherThanGoodwill2023-12-3107254368ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3107254368ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: 07254368 (England and Wales)
























FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

VAXAID LTD.

VAXAID LTD. (REGISTERED NUMBER: 07254368)

CONTENTS OF THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


VAXAID LTD.

COMPANY INFORMATION
For The Year Ended 31 December 2024







DIRECTOR: C A Pallister





SECRETARY: J Mozalski





REGISTERED OFFICE: Unit 1, Horbury Junction Industrial Park
Calder Vale Road
Horbury
Wakefield
WF4 5ER





REGISTERED NUMBER: 07254368 (England and Wales)





AUDITORS: Fortus Audit LLP
Equinox House
Clifton Park, Shipton Road
York
Yorkshire
YO30 5PA

VAXAID LTD. (REGISTERED NUMBER: 07254368)

BALANCE SHEET
31 December 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 3,311 4,060

CURRENT ASSETS
Debtors 5 424,807 393,976
Cash at bank 4,970 38,938
429,777 432,914
CREDITORS
Amounts falling due within one year 6 324,542 323,837
NET CURRENT ASSETS 105,235 109,077
TOTAL ASSETS LESS CURRENT LIABILITIES 108,546 113,137

PROVISIONS FOR LIABILITIES 873 1,015
NET ASSETS 107,673 112,122

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 107,672 112,121
107,673 112,122

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 25 September 2025 and were signed by:





C A Pallister - Director


VAXAID LTD. (REGISTERED NUMBER: 07254368)

NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2024


1. STATUTORY INFORMATION

Vaxaid Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


The level of rounding used in the financial statements is to the nearest £1.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The Company, and the group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent group are considered eligible for the exemption to prepare consolidated accounts.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

All intangible assets are considered to have finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

The estimated useful lives range as follows:

Website - 5 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


VAXAID LTD. (REGISTERED NUMBER: 07254368)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 31 December 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. As a result, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2024 5,075
Additions 333
At 31 December 2024 5,408
AMORTISATION
At 1 January 2024 1,015
Charge for year 1,082
At 31 December 2024 2,097
NET BOOK VALUE
At 31 December 2024 3,311
At 31 December 2023 4,060

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors - 2,215
Amounts owed by group undertakings 424,740 391,761
Other debtors 67 -
424,807 393,976

VAXAID LTD. (REGISTERED NUMBER: 07254368)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 31 December 2024


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Amounts owed to group undertakings 321,042 318,837
Other creditors 3,500 5,000
324,542 323,837

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Frances Howard (Senior Statutory Auditor)
for and on behalf of Fortus Audit LLP

8. ULTIMATE CONTROLLING PARTY

The ultimate parent company is Ultramax Products Limited, a company registered in England and Wales under Company Number 05483439.

There is not considered to be an ultimate controlling party by virtue of the share holdings.